Ribomic Inc. (TSE: 4591)
Health Care · Biotechnology · JP
¥81.00
+2.53% today · -20.6% 1Y
Ribomic Inc. (TSE: 4591) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.81M and employs 25 people.
Over the last twelve months the share price has lost 20.6%, trading between 57.00 and 120.00.
Tweenvest scores Ribomic Inc. across four factors: quality 30/100, value 52/100. Its strongest factor is value.
4591 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.81M
- Revenue (TTM)
- $46.14K
- P/E
- —
- EPS
- -22.69
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- ¥120.00
- 52-week low
- ¥57.00
- Avg volume (3M)
- —
- Shares outstanding
- 56.55M
- Employees
- 25
- Next earnings
- —
About Ribomic Inc.
Ribomic Inc. is a Japanese biopharmaceutical company dedicated to identifying and advancing medicinal compounds. The firm employs RNA aptamers in its drug development efforts, targeting various significant health issues such as wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma. Furthermore, Ribomic manufactures specialized separating agents used for the affinity purification of human IgG and Fc-fusion proteins. Established in 2003, the company's main operations are based in Tokyo, Japan.
- ISIN
- JP3974850004
- Founded
- 2003
- Listed since
- Sep 25, 2014
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.